Market Tracker

06/30 5:16pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

13.44
Delayed Data
As of Jun 30
 +0.21 / +1.59%
Today’s Change
12.45
Today|||52-Week Range
22.48
-32.29%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close13.23
Today’s open13.21
Day’s range13.11 - 13.45
Volume177,500
Average volume (3 months)303,333
Market cap$472.4M
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+30.00%
Earnings growth (this year)+8.33%
Earnings growth (next 5 years)+12.25%
Revenue growth (last year)+45.48%
P/E ratioNM
Price/Sales1.64
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...+0.02+0.35%
FLXNFlexion Therapeutics...+0.08+0.57%
AMRNAmarin Corporation P...-0.01-0.46%
ARWRArrowhead Pharmaceut...-0.09-1.66%
Data as of 4:14pm ET, 06/30/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.32
Annual revenue (last year)$402.4M
Annual profit (last year)-$2.3M
Net profit margin-0.57%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts